Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Lauria · SciRah

Researcher profile · Semantic Scholar

A. Lauria

Share profile

A. Lauria — researcher profile on SciRah

h-index: 11
Works: 28
Citations: 425

Most-cited papers

Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?
E. Mannucci, I. Dicembrini, A. Lauria, P. Pozzilli
2013Diabetes Care139 citations Open access
Semantic Scholar
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes
E. Maddaloni, L. D'Onofrio, A. Lauria, A. Maurizi +6 more
2014Journal of Endocrinological Investigation65 citations
Semantic Scholar
Raman Spectroscopy Applied to Parathyroid Tissues: A New Diagnostic Tool to Discriminate Normal Tissue from Adenoma.
A. Palermo, M. Fosca, G. Tabacco, F. Marini +13 more
2018Analytical Chemistry35 citations
Semantic Scholar
Effectiveness and Safety of Golimumab in Treating Outpatient Ulcerative Colitis: A Real-Life Prospective, Multicentre, Observational Study in Primary Inflammatory Bowel Diseases Centers.
A. Tursi, L. Allegretta, N. Buccianti, N. della Valle +16 more
2017Journal of Gastrointestinal and Liver Diseases30 citations Open access
Semantic Scholar
A Novel Insulin Unit Calculator for the Management of Type 1 Diabetes
A. Maurizi, A. Lauria, D. Maggi, A. Palermo +3 more
2011Diabetes Technology & Therapeutics27 citations
Semantic Scholar
Vedolizumab is effective and safe in real-life treatment of inflammatory bowel diseases outpatients: A multicenter, observational study in primary inflammatory bowel disease centers.
A. Tursi, G. Mocci, R. Faggiani, L. Allegretta +20 more
2019European journal of internal medicine22 citations
Semantic Scholar
Infliximab biosimilar CT-P13 is effective and safe in treating inflammatory bowel diseases: a real-life multicenter, observational study in Italian primary inflammatory bowel disease centers
A. Tursi, G. Mocci, R. Faggiani, L. Allegretta +18 more
2019Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology20 citations Open access
Semantic Scholar
Blue eyes as a risk factor for type 1 diabetes
E. di Stasio, D. Maggi, E. Berardesca, G. C. Marulli +10 more
2011Diabetes/Metabolism Research Reviews16 citations
Semantic Scholar
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
F. Bossa, G. Biscaglia, M. Valvano, G. Costantino +31 more
2019Digestive Diseases and Sciences15 citations
Semantic Scholar
Continuous subcutaneous insulin infusion (CSII) in inpatient setting: unmet needs and the proposal of a CSII unit.
L. Morviducci, A. Di Flaviani, A. Lauria, D. Pitocco +3 more
2011Diabetes Technology & Therapeutics14 citations
Semantic Scholar
Testing for Afirma in Thyroid Nodules with High-Risk Indeterminate Cytology (TIR3B): First Italian Experience
Massimiliano Andrioli, S. Carocci, S. Alessandrini, M. Amini +5 more
2020Endocrine pathology12 citations
Semantic Scholar
Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn’s disease: results from an Italian multicenter study
G. Mocci, A. Tursi, G. Maconi, G. Cataletti +60 more
2023Expert Opinion on Biological Therapy11 citations
Semantic Scholar
Time dependent C-peptide decline in 4411 patients with recent onset type 1 diabetes followed for up to 10 years: a meta-analysis from 8 European centres
P. Pozzilli, N. Schloot, N. Hosszúfalusi, A. Lauria +11 more
20116 citations
Semantic Scholar
Clinical and economic impact of infliximab one-hour infusion protocol in patients with inflammatory bowel diseases: A multicenter study
A. Viola, G. Costantino, A. Privitera, F. Bossa +5 more
2017World journal of gastrointestinal pharmacology and therapeutics5 citations Open access
Semantic Scholar
Imaging in Endocrinology
P. Pozzilli, A. Lenzi, B. Clarke, W. Young +7 more
20134 citations
Semantic Scholar
P621 Efficacy and safety of golimumab in ulcerative colitis. Preliminary data from a multicenter Italian study.
Fabrizio Bossa, Maria Rosa Valvano, G. Costantino, E. Vinci +18 more
2017Journal of Crohn's & Colitis1 citations
Semantic Scholar
P.06.23 INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS: LACK OF PREDICTIVE FACTORS FOR RESPONSE IN A LARGE MULTICENTER SERIES
M. Cappello, M. Mazza, G. Costantino, W. Fries +11 more
20141 citations Open access
Semantic Scholar
Su1237 A Retrospective Multicenter Survey on Infliximab Efficacy and Safety in Moderate-to-Severe and Steroid-Dependent Ulcerative Colitis
M. Cappello, M. Mazza, G. Costantino, W. Fries +9 more
20131 citations Open access
Semantic Scholar
Blue eyes and fair skin as risk factors for type I diabetes.
E. di Stasio, D. Maggi, E. Berardesca, G. Marulli +10 more
20111 citations
Semantic Scholar
P505 Real word long-term efficacy and safety of vedolizumab in managing ulcerative colitis versus crohn’s disease: results from “long vedo” italian multicenter study
G. Mocci, G. Maconi, F. Onidi, G. Cataletti +36 more
2023Journal of Crohn's & Colitis0 citations Open access
Semantic Scholar
T.06.8 REAL WORD LONG-TERM EFFICACY AND SAFETY OF VEDOLIZUMAB IN MANAGING ULCERATIVE COLITIS VERSUS CROHN'S DISEASE: RESULTS FROM “LONG VEDO” ITALIAN MULTICENTER STUDY
G. Mocci, G. Maconi, G. Cataletti, B. Mantia +44 more
2023Digestive and Liver Disease0 citations
Semantic Scholar
Rapid Improvement of Metabolic Control in Type 1 Diabetes after Transition from Paediatric Clinics to an Adult Diabetes Center
A. Maurizi, Silvia Pieralice, D. Tuccinardi, C. Guglielmi +5 more
2018Diabetes0 citations
Semantic Scholar
P447 Infliximab in the treatment of moderate-to-severe ulcerative colitis: Results of a large multicenter Italian survey
M. Cappello, M. Mazza, G. Costantino, W. Fries +10 more
20140 citations
Semantic Scholar
P487 Infliximab in moderate-to-severe ulcerative colitis: efficacy and safety in a “real life” retrospective multicenter study from southern Italy
M. Cappello, M. Mazza, G. Costantino, W. Fries +9 more
20130 citations Open access
Semantic Scholar
OC.08.6 EFFICACY OF INFLIXIMAB IN “REAL PRACTICE” PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A RETROSPECTIVE MULTICENTER STUDY FROM SOUTHERN ITALY
M. Cappello, M. Mazza, G. Costantino, W. Fries +9 more
20130 citations
Semantic Scholar
P.1.315: THERAPY-RELATED ADVERSE EVENTS IN CROHN'S DISEASE (CD) – A COMPARISON BETWEEN THIOPURINES, INFLIXIMAB AND COMBINED THERAPY
W. Fries, M. Mastronardi, M. Cappello, L. Grossi +8 more
20110 citations
Semantic Scholar
OC.07.5: EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
W. Fries, A. Privitera, M. L. Lo Presti, M. Mastronardi +6 more
20110 citations
Semantic Scholar
P.69 A “REAL LIVE” EXPERIENCE OF INFLIXIMAB USE FOR CROHN'S DISEASE IN SOUTHERN ITALY
M. L. Lo Presti, A. Privitera, M. Cappello, A. Lauria +4 more
20100 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Privitera×11
Invite
A. Privitera — researcher profile on SciRah
M. Cappello×11
Invite
M. Cappello — researcher profile on SciRah
P. Pozzilli×10
Invite
P. Pozzilli — researcher profile on SciRah
N. della Valle×10
Invite
N. della Valle — researcher profile on SciRah

×10

Invite

W. Fries — researcher profile on SciRah

N. Buccianti×8

Invite

N. Buccianti — researcher profile on SciRah

G. Costantino×8

Invite

G. Costantino — researcher profile on SciRah

Invite

A. Tursi — researcher profile on SciRah

Invite

G. Pranzo — researcher profile on SciRah

Invite

L. Sebkova — researcher profile on SciRah

Invite

F. Bossa — researcher profile on SciRah

Invite

L. Grossi — researcher profile on SciRah